Gene Symbol | Pearson Correlation Coefficient |
---|---|
NUP98 | 0.882 |
TMEM43 | 0.875 |
TXLNA | 0.856 |
XRN2 | 0.855 |
SEC61A1 | 0.855 |
RAF1 | 0.854 |
WDR1 | 0.853 |
NUP188 | 0.853 |
CDC42SE1 | 0.848 |
UBE2H | 0.843 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
OR4F5 | -0.644 |
OR4F29 | -0.632 |
RERGL | -0.203 |
KLRC2 | -0.194 |
ACY3 | -0.19 |
HES5 | -0.181 |
OR6F1 | -0.159 |
CRH | -0.154 |
REN | -0.15 |
IAPP | -0.149 |
ID | Drug Name | Drug Type | CAS Num | Status | Role |
---|---|---|---|---|---|
DB01133 | Tiludronic acid | Small Molecule | 89987-06-4 | Approved|Investigational | Target |
DB01734 | 3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid | Small Molecule | Experimental | Target | |
DB01820 | Compound 12, N-Acetyl-4-[(Carboxycarbonyl)(2-Carboxyphenyl)Amino]-N-Pentyl-1-Napthylalaniamide | Small Molecule | Experimental | Target | |
DB02014 | Compound 9 | Small Molecule | - | Experimental | Target |
DB02072 | 2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Thiopyran-3-Carboxylic Acid | Small Molecule | Experimental | Target | |
DB02259 | 3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide | Small Molecule | Experimental | Target | |
DB02420 | [[4-(Aminomethyl)Phenyl]Amino]Oxo-Acetic Acid, | Small Molecule | Experimental | Target | |
DB02436 | 2-{4-[(2s)-2-[({[(1s)-1-Carboxy-2-Phenylethyl]Amino}Carbonyl)Amino]-3-Oxo-3-(Pentylamino)Propyl]Phenoxy}Malonic Acid | Small Molecule | Experimental | Target | |
DB02615 | Compound 19 | Small Molecule | Experimental | Target | |
DB02620 | Sp7343-Sp7964 | Small Molecule | Experimental | Target | |
DB02622 | 2-(Oxalyl-Amino)-Benzoic Acid | Small Molecule | Experimental | Target | |
DB02651 | {[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid) | Small Molecule | Experimental | Target | |
DB02662 | Novo Nordisk a/S Compound | Small Molecule | Experimental | Target | |
DB02784 | N-[4-(2-{2-[3-(2-Bromo-Acetylamino)-Propionylamino]-3-Hydroxy-Propionylamino}-Ethyl)-Phenyl]-Oxalamic Acid | Small Molecule | Experimental | Target | |
DB02827 | 7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid | Small Molecule | Experimental | Target | |
DB02977 | PNU177836 | Small Molecule | Experimental | Target | |
DB03102 | 2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid | Small Molecule | Experimental | Target | |
DB03154 | {[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid | Small Molecule | Experimental | Target | |
DB03311 | 3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide | Small Molecule | Experimental | Target | |
DB03483 | 4-Benzoylamino-4-{1-{1-Carbamoyl-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-Butyric Acid | Small Molecule | Experimental | Target | |
DB03557 | N-{1-[5-(1-Carbamoyl-2-Mercapto-Ethylcarbamoyl)-Pentylcarbamoyl]-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethyl}-3-{2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Acetylamino}-Succinamic Acid | Small Molecule | Experimental | Target | |
DB03661 | Cysteinesulfonic Acid | Small Molecule | Experimental | Target | |
DB03670 | 2-(Oxalyl-Amino)-4,5,6,7-Tetrahydro-Thieno[2,3-C]Pyridine-3-Carboxylic Acid | Small Molecule | Experimental | Target | |
DB03714 | 4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid | Small Molecule | Experimental | Target | |
DB03982 | Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid | Small Molecule | Experimental | Target | |
DB04001 | 6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid | Small Molecule | Experimental | Target | |
DB04088 | N-(Allyloxycarbonyl)-4-[N-(Carboxy-Formyl)-2-(Benzoic Acid)-Amino]-L-Phenylalaninyl-Amino-Butyloxy-(6-Hydroxy-Benzoic Acid Methyl Ester) | Small Molecule | Experimental | Target | |
DB04142 | 3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide | Small Molecule | Experimental | Target | |
DB04204 | [(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid | Small Molecule | Experimental | Target | |
DB04285 | {4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid | Small Molecule | Experimental | Target | |
DB04525 | 2-(Carboxymethoxy)-5-[(2s)-2-({(2s)-2-[(3-Carboxypropanoyl)Amino] -3-Phenylpropanoyl}Amino)-3-Oxo-3-(Pentylamino)Propyl]Benzoic Acid | Small Molecule | Experimental | Target | |
DB04800 | 1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID | Small Molecule | Experimental | Target | |
DB05506 | ISIS 113715 | Small Molecule | - | Investigational | Target |
DB06333 | Trodusquemine | BiotechDrug | 186139-09-3 | Investigational | Target |
DB06521 | Ertiprotafib | Small Molecule | 251303-04-5 | Investigational | Target |
DB06829 | 4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID | Small Molecule | Experimental | Target | |
DB06887 | [(3S)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid | Small Molecule | Experimental | Target | |
DB07130 | 4-BROMO-3-(CARBOXYMETHOXY)-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID | Small Molecule | Experimental | Target | |
DB07134 | 5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE | Small Molecule | Experimental | Target | |
DB07197 | 4-BROMO-3-(CARBOXYMETHOXY)-5-(4-HYDROXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID | Small Molecule | Experimental | Target | |
DB07263 | [{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid | Small Molecule | Experimental | Target | |
DB07289 | 5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID | Small Molecule | Experimental | Target | |
DB07295 | 2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID | Small Molecule | Experimental | Target | |
DB07298 | 3-(CARBOXYMETHOXY)THIENO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID | Small Molecule | Experimental | Target | |
DB07480 | 4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN | Small Molecule | Experimental | Target | |
DB07651 | N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE | Small Molecule | Experimental | Target | |
DB07719 | [(3R)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid | Small Molecule | Experimental | Target | |
DB07730 | 5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE | Small Molecule | Experimental | Target | |
DB08001 | 5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID | Small Molecule | Experimental | Target | |
DB08003 | ISOTHIAZOLIDINONE ANALOG | Small Molecule | Experimental | Target | |
DB08147 | 4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid | Small Molecule | Experimental | Target | |
DB08371 | PARA-(BENZOYL)-PHENYLALANINE | Small Molecule | Experimental | Target | |
DB08397 | 6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID | Small Molecule | Experimental | Target | |
DB08549 | (3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER | Small Molecule | Experimental | Target | |
DB08591 | 5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE | Small Molecule | Experimental | Target | |
DB08593 | 1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE | Small Molecule | Experimental | Target | |
DB08783 | (4-{(2S)-2-[(tert-butoxycarbonyl)amino]-3-methoxy-3-oxopropyl}phenyl)methaneseleninic acid | Small Molecule | Experimental | Target |
ID | Drug Name | Action | PubMed |
---|---|---|---|
C040756 | 1,2-naphthoquinone | "1,2-naphthoquinone results in decreased activity of PTPN1 protein" | 24067727 |
C111118 | 2',3,3',4',5-pentachloro-4-hydroxybiphenyl | "2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of PTPN1 mRNA" | 19114083 |
C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PTPN1 protein" | 24978599 |
C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PTPN1 protein" | 24978599 |
C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PTPN1 protein" | 24978599 |
C016403 | 2,4-dinitrotoluene | "2,4-dinitrotoluene affects the expression of PTPN1 mRNA" | 21346803 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of PTPN1 mRNA] | 12710931 |
C009407 | 2,5,2',5'-tetrachlorobiphenyl | "2,5,2',5'-tetrachlorobiphenyl results in decreased expression of PTPN1 mRNA" | 23829299 |
C023514 | 2,6-dinitrotoluene | "2,6-dinitrotoluene affects the expression of PTPN1 mRNA" | 21346803 |
C405943 | 2-(oxalylamino)benzoic acid | 2-(oxalylamino)benzoic acid analog binds to and results in decreased activity of PTPN1 protein | 10744717 |
C405943 | 2-(oxalylamino)benzoic acid | 2-(oxalylamino)benzoic acid results in decreased activity of PTPN1 protein | 10744717 |
C572491 | 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol | 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol results in increased expression of PTPN1 protein | 26194647 |
C023035 | 3,4,5,3',4'-pentachlorobiphenyl | "3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PTPN1 mRNA" | 23196670 |
C441128 | 3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate | "3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate results in decreased activity of PTPN1 protein" | 20075852 |
C441128 | 3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate | "3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate results in decreased activity of PTPN1 protein" | 21341673|2428756 |
C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in decreased expression of PTPN1 mRNA | 12419474 |
D000082 | Acetaminophen | Acetaminophen affects the expression of PTPN1 mRNA | 17562736 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Pyruvaldehyde results in increased expression of PTPN1 protein] | 22917016 |
D000171 | Acrolein | Acrolein results in decreased activity of PTPN1 protein | 17655273 |
D000171 | Acrolein | Vanadates inhibits the reaction [Acrolein results in decreased activity of PTPN1 protein] | 17655273 |
D000244 | Adenosine Diphosphate | Adenosine Diphosphate results in increased glutathionylation of PTPN1 protein | 16781456 |
D000244 | Adenosine Diphosphate | CAT protein inhibits the reaction [Adenosine Diphosphate results in increased glutathionylation of PTPN1 protein] | 16781456 |
D000517 | alpha-Chlorohydrin | alpha-Chlorohydrin analog results in increased expression of PTPN1 protein | 26072098 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of PTPN1 mRNA | 16483693 |
D000728 | Androgens | Androgens affects the expression of and affects the activity of PTPN1 protein | 16652382 |
C031385 | anthranilic acid | [oxovanadium IV binds to anthranilic acid analog] which results in decreased activity of PTPN1 protein | 22864521 |
D018501 | Antirheumatic Agents | Antirheumatic Agents results in decreased expression of PTPN1 mRNA | 24449571 |
C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of PTPN1 mRNA | 22521957 |
D019817 | Benzoic Acid | Benzoic Acid analog inhibits the reaction [PTPN1 protein results in increased hydrolysis of nitrophenylphosphate] | 24287560 |
D019817 | Benzoic Acid | Benzoic Acid analog results in decreased activity of PTPN1 protein | 24287560 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of PTPN1 mRNA | 22228805 |
D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PTPN1 mRNA" | 19150397 |
D004958 | Estradiol | Estradiol affects the expression of PTPN1 mRNA | 22574217 |
C044887 | beta-methylcholine | beta-methylcholine affects the expression of PTPN1 mRNA | 21179406 |
C074212 | bis(maltolato)oxovanadium(IV) | bis(maltolato)oxovanadium(IV) results in decreased activity of PTPN1 protein | 22864521 |
C006780 | bisphenol A | bisphenol A affects the expression of PTPN1 mRNA | 21786754 |
C006780 | bisphenol A | bisphenol A affects the expression of PTPN1 mRNA | 21786754 |
C006780 | bisphenol A | bisphenol A results in increased expression of PTPN1 mRNA | 12075121|2518105 |
C006780 | bisphenol A | bisphenol A results in increased methylation of PTPN1 gene | 28505145 |
D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine results in increased oxidation of PTPN1 protein | 20482862 |
C055494 | caffeic acid phenethyl ester | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in increased expression of PTPN1 mRNA | 20360939 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of PTPN1 mRNA | 26739621 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of PTPN1 protein | 26739621 |
D002392 | Catechin | [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of PTPN1 mRNA | 24763279 |
C100187 | chloropicrin | chloropicrin results in increased expression of PTPN1 mRNA | 26352163 |
D002791 | Cholesterol, Dietary | "[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of PTPN1 protein" | 19509184 |
D002857 | Chromium | Chromium results in decreased expression of and results in decreased activity of PTPN1 protein | 16424121 |
C079689 | chromium tripicolinate | chromium tripicolinate results in decreased expression of and results in decreased activity of PTPN1 protein | 16424121 |
C012843 | cinnamic aldehyde | cinnamic aldehyde analog results in decreased activity of PTPN1 protein | 12186556 |
C007095 | cobaltiprotoporphyrin | [SIRT1 gene mutant form co-treated with cobaltiprotoporphyrin] results in increased expression of PTPN1 mRNA | 26026874 |
C007095 | cobaltiprotoporphyrin | [SIRT1 gene mutant form co-treated with cobaltiprotoporphyrin] results in increased expression of PTPN1 protein | 26026874 |
C007095 | cobaltiprotoporphyrin | stannous mesoporphyrin inhibits the reaction [[SIRT1 gene mutant form co-treated with cobaltiprotoporphyrin] results in increased expression of PTPN1 protein] | 26026874 |
D003300 | Copper | Copper results in decreased activity of PTPN1 protein | 20383386 |
D003375 | Coumestrol | Coumestrol results in decreased expression of PTPN1 mRNA | 19167446 |
C037886 | cryptotanshinone | cryptotanshinone results in decreased activity of PTPN1 protein | 29031618 |
D003471 | Cuprizone | Cuprizone results in decreased expression of PTPN1 mRNA | 26577399 |
C010902 | decabromobiphenyl ether | decabromobiphenyl ether results in increased expression of PTPN1 mRNA | 23640034 |
D003907 | Dexamethasone | [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of PTPN1 mRNA] | 26739621 |
D003907 | Dexamethasone | [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of PTPN1 protein] | 26739621 |
D003907 | Dexamethasone | PTPN1 protein inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA]] | 26739621 |
D003907 | Dexamethasone | PTPN1 protein inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]] | 26739621 |
D003907 | Dexamethasone | PTPN1 protein inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA]] | 26739621 |
D003907 | Dexamethasone | PTPN1 protein inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein]] | 26739621 |
D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in increased expression of PTPN1 mRNA | 21266533 |
D004008 | Diclofenac | Diclofenac results in increased expression of PTPN1 mRNA | 26934552 |
D004041 | Dietary Fats | "[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of PTPN1 protein" | 19509184 |
D004041 | Dietary Fats | Dietary Fats results in increased expression of PTPN1 protein | 22509299|2741725 |
D004041 | Dietary Fats | "methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate inhibits the reaction [Dietary Fats results in increased expression of PTPN1 protein]" | 27417254 |
D004041 | Dietary Fats | PTPN1 gene mutant form results in increased susceptibility to Dietary Fats | 22509299 |
D004041 | Dietary Fats | [PTPN1 gene mutant form results in increased susceptibility to Dietary Fats] which results in increased activity of and results in increased phosphorylation of EIF2AK3 protein | 22509299 |
D004041 | Dietary Fats | [PTPN1 gene mutant form results in increased susceptibility to Dietary Fats] which results in increased cleavage of ATF6 protein | 22509299 |
D004041 | Dietary Fats | [PTPN1 gene mutant form results in increased susceptibility to Dietary Fats] which results in increased cleavage of DDIT3 protein | 22509299 |
D004041 | Dietary Fats | [PTPN1 gene mutant form results in increased susceptibility to Dietary Fats] which results in increased expression of DDIT3 mRNA | 22509299 |
D004041 | Dietary Fats | [PTPN1 gene mutant form results in increased susceptibility to Dietary Fats] which results in increased expression of HSPA5 mRNA | 22509299 |
D004041 | Dietary Fats | [PTPN1 gene mutant form results in increased susceptibility to Dietary Fats] which results in increased expression of HSPA5 protein | 22509299 |
D004041 | Dietary Fats | [PTPN1 gene mutant form results in increased susceptibility to Dietary Fats] which results in increased expression of XBP1 protein | 22509299 |
D004041 | Dietary Fats | [PTPN1 gene mutant form results in increased susceptibility to Dietary Fats] which results in increased phosphorylation of EIF2S1 protein | 22509299 |
D004041 | Dietary Fats | [PTPN1 gene mutant form results in increased susceptibility to Dietary Fats] which results in increased splicing of XBP1 mRNA | 22509299 |
D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in increased expression of PTPN1 mRNA | 20360939 |
D002117 | Calcitriol | Calcitriol results in increased expression of PTPN1 mRNA | 16002434 |
C472511 | dimethylarsinous acid | dimethylarsinous acid binds to PTPN1 protein | 22771847 |
C472511 | dimethylarsinous acid | dimethylarsinous acid results in decreased activity of PTPN1 protein | 22771847 |
D004147 | Dioxins | Dioxins affects the expression of PTPN1 mRNA | 20463971 |
D004229 | Dithiothreitol | Dithiothreitol inhibits the reaction [Hydrogen Peroxide results in increased glutathionylation of PTPN1 protein] | 16781456 |
D004791 | Enzyme Inhibitors | Enzyme Inhibitors results in decreased activity of PTPN1 protein | 22366233 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of PTPN1 mRNA | 17606305 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of PTPN1 mRNA | 17555576 |
D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PTPN1 mRNA | 17942748 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of PTPN1 mRNA | 12075121|1265503 |
D005419 | Flavonoids | Flavonoids results in decreased expression of PTPN1 mRNA | 18035473 |
D005632 | Fructose | "[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of PTPN1 protein" | 19509184 |
C015896 | fucosterol | fucosterol results in decreased activity of PTPN1 protein | 23994501 |
C000599091 | fumosorinone | fumosorinone results in decreased expression of PTPN1 protein | 25796170 |
C000599091 | fumosorinone | fumosorinone results in decreased expression of PTPN1 protein | 25796170 |
D019833 | Genistein | Genistein results in increased expression of PTPN1 mRNA | 12075121 |
C063349 | glisoflavone | glisoflavone results in decreased activity of PTPN1 protein | 20724155 |
C004312 | glycidol | glycidol results in increased expression of PTPN1 mRNA | 24915197 |
C511402 | Grape Seed Proanthocyanidins | [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of PTPN1 mRNA | 24763279 |
D017313 | Fenretinide | Fenretinide results in increased expression of PTPN1 mRNA | 28973697 |
D006861 | Hydrogen Peroxide | Dithiothreitol inhibits the reaction [Hydrogen Peroxide results in increased glutathionylation of PTPN1 protein] | 16781456 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased glutathionylation of PTPN1 protein | 16781456 |
D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of PTPN1 mRNA | 25613284 |
D015056 | 1-Methyl-3-isobutylxanthine | [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of PTPN1 mRNA] | 26739621 |
D015056 | 1-Methyl-3-isobutylxanthine | [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of PTPN1 protein] | 26739621 |
D015056 | 1-Methyl-3-isobutylxanthine | PTPN1 protein inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA]] | 26739621 |
D015056 | 1-Methyl-3-isobutylxanthine | PTPN1 protein inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]] | 26739621 |
D015056 | 1-Methyl-3-isobutylxanthine | PTPN1 protein inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA]] | 26739621 |
D015056 | 1-Methyl-3-isobutylxanthine | PTPN1 protein inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein]] | 26739621 |
C040920 | isoliquiritigenin | isoliquiritigenin inhibits the reaction [INS1 protein results in decreased activity of and results in increased oxidation of PTPN1 protein] | 27117918 |
C512915 | isothiazolidinone | isothiazolidinone analog results in decreased activity of PTPN1 protein | 17028182 |
D048628 | Ketolides | Ketolides analog results in increased expression of PTPN1 mRNA | 24967691 |
D008095 | Lithocholic Acid | Lithocholic Acid analog results in decreased activity of PTPN1 protein | 23067554 |
D008095 | Lithocholic Acid | Lithocholic Acid results in decreased activity of PTPN1 protein | 23067554 |
D008627 | Mercuric Chloride | Mercuric Chloride affects the expression of PTPN1 mRNA | 20353558 |
C445068 | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate | "methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate inhibits the reaction [Dietary Fats results in increased expression of PTPN1 protein]" | 27417254 |
C004925 | methylmercuric chloride | methylmercuric chloride results in decreased activity of PTPN1 protein | 28958600 |
D018817 | N-Methyl-3,4-methylenedioxyamphetamine | "N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PTPN1 mRNA" | 20188158 |
D015655 | 1-Methyl-4-phenylpyridinium | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of PTPN1 mRNA] | 12710931 |
C406082 | monomethylarsonous acid | monomethylarsonous acid binds to PTPN1 protein | 22771847 |
C406082 | monomethylarsonous acid | monomethylarsonous acid results in decreased activity of PTPN1 protein | 22771847 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in increased expression of PTPN1 mRNA" | 25554681 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of PTPN1 mRNA" | 25554681|2562005 |
C008644 | nitrophenylphosphate | Benzoic Acid analog inhibits the reaction [PTPN1 protein results in increased hydrolysis of nitrophenylphosphate] | 24287560 |
C008644 | nitrophenylphosphate | PTPN1 protein results in increased hydrolysis of nitrophenylphosphate | 24287560 |
C008644 | nitrophenylphosphate | Thiazolidines analog inhibits the reaction [PTPN1 protein results in increased hydrolysis of nitrophenylphosphate] | 24287560 |
D009942 | Organometallic Compounds | Organometallic Compounds binds to and results in decreased activity of PTPN1 protein | 20383386 |
D009942 | Organometallic Compounds | Organometallic Compounds results in decreased activity of PTPN1 protein | 22027948 |
C075743 | oxovanadium IV | [oxovanadium IV binds to anthranilic acid analog] which results in decreased activity of PTPN1 protein | 22864521 |
C075743 | oxovanadium IV | [oxovanadium IV binds to salicylideneaniline analog] which results in decreased activity of PTPN1 protein | 22864521 |
C075743 | oxovanadium IV | [oxovanadium IV binds to Schiff Bases] which results in decreased activity of PTPN1 protein | 22864521 |
D019308 | Palmitic Acid | Palmitic Acid results in increased expression of PTPN1 protein | 22509299 |
C016030 | pantogab | pantogab results in increased expression of PTPN1 mRNA | 17379144 |
C410127 | PCB 180 | "[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PTPN1 protein" | 24978599 |
C410127 | PCB 180 | "[2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PTPN1 protein" | 24978599 |
C076715 | pervanadate | pervanadate results in decreased activity of PTPN1 protein | 22384078 |
C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PTPN1 mRNA | 19710929 |
C006253 | pirinixic acid | pirinixic acid results in increased expression of PTPN1 mRNA | 18301758 |
D010936 | Plant Extracts | Plant Extracts results in decreased activity of PTPN1 protein | 18534569 |
C008704 | pyrithione | [Zinc co-treated with pyrithione] results in decreased activity of PTPN1 protein | 22374166 |
D011765 | Pyruvaldehyde | Acetylcysteine inhibits the reaction [Pyruvaldehyde results in increased expression of PTPN1 protein] | 22917016 |
D011765 | Pyruvaldehyde | NFE2L2 protein affects the reaction [resveratrol inhibits the reaction [Pyruvaldehyde results in increased expression of PTPN1 protein]] | 22917016 |
D011765 | Pyruvaldehyde | Pyruvaldehyde results in increased expression of PTPN1 protein | 22917016 |
D011765 | Pyruvaldehyde | rosiglitazone inhibits the reaction [Pyruvaldehyde results in increased expression of PTPN1 protein] | 22917016 |
D011794 | Quercetin | Quercetin inhibits the reaction [TNF protein results in increased expression of PTPN1 mRNA] | 20943792 |
C059514 | resveratrol | NFE2L2 protein affects the reaction [resveratrol inhibits the reaction [Pyruvaldehyde results in increased expression of PTPN1 protein]] | 22917016 |
C059514 | resveratrol | resveratrol results in increased activity of PTPN1 protein | 18567737 |
C059514 | resveratrol | [resveratrol results in increased activity of PTPN1 protein] which results in decreased phosphorylation of PDGFRB protein | 18567737 |
C059514 | resveratrol | [[resveratrol results in increased activity of PTPN1 protein] which results in decreased phosphorylation of PDGFRB protein] which results in decreased phosphorylation of MAPK1 protein | 18567737 |
C059514 | resveratrol | [[resveratrol results in increased activity of PTPN1 protein] which results in decreased phosphorylation of PDGFRB protein] which results in decreased phosphorylation of MAPK3 protein | 18567737 |
C059514 | resveratrol | PTPN1 protein results in increased susceptibility to resveratrol | 20026400 |
C059514 | resveratrol | resveratrol inhibits the reaction [IRS2 gene mutant form results in increased activity of PTPN1 protein] | 20028942 |
C059514 | resveratrol | resveratrol inhibits the reaction [IRS2 gene mutant form results in increased expression of PTPN1 mRNA] | 20028942|2580821 |
C059514 | resveratrol | resveratrol inhibits the reaction [IRS2 gene mutant form results in increased expression of PTPN1 protein] | 25808216 |
C059514 | resveratrol | resveratrol inhibits the reaction [Streptozocin results in increased expression of PTPN1 protein] | 25808216 |
C059514 | resveratrol | resveratrol results in increased expression of PTPN1 protein | 25505154 |
C089730 | rosiglitazone | rosiglitazone inhibits the reaction [Pyruvaldehyde results in increased expression of PTPN1 protein] | 22917016 |
C022850 | rutamarin | rutamarin results in decreased activity of PTPN1 protein | 22384078 |
C510217 | salicylideneaniline | [oxovanadium IV binds to salicylideneaniline analog] which results in decreased activity of PTPN1 protein | 22864521 |
D012545 | Schiff Bases | [oxovanadium IV binds to Schiff Bases] which results in decreased activity of PTPN1 protein | 22864521 |
D064586 | Selenic Acid | Selenic Acid results in decreased activity of PTPN1 protein | 22366233 |
D064586 | Selenic Acid | Selenic Acid results in increased expression of PTPN1 mRNA | 16443359 |
D012643 | Selenium | Selenium results in decreased glutathionylation of PTPN1 protein | 19022953 |
D012643 | Selenium | Selenium results in increased expression of PTPN1 protein | 19022953 |
D012645 | Selenomethionine | Selenomethionine results in decreased expression of PTPN1 mRNA | 23399444 |
C078903 | seocalcitol | seocalcitol results in increased expression of PTPN1 mRNA | 12040012 |
D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of PTPN1 mRNA | 23221170 |
D018038 | Sodium Selenite | Sodium Selenite results in decreased activity of PTPN1 protein | 22366233 |
D018038 | Sodium Selenite | Sodium Selenite results in increased expression of PTPN1 mRNA | 16443359 |
D053260 | Soot | Soot results in increased expression of PTPN1 mRNA | 26551751 |
C518404 | stannous mesoporphyrin | stannous mesoporphyrin inhibits the reaction [[SIRT1 gene mutant form co-treated with cobaltiprotoporphyrin] results in increased expression of PTPN1 protein] | 26026874 |
D013311 | Streptozocin | resveratrol inhibits the reaction [Streptozocin results in increased expression of PTPN1 protein] | 25808216 |
D013311 | Streptozocin | Streptozocin results in increased expression of PTPN1 protein | 25808216 |
D013629 | Tamoxifen | Tamoxifen affects the expression of PTPN1 mRNA | 17555576 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of PTPN1 mRNA | 12377990 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of PTPN1 mRNA | 21570461 |
D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PTPN1 mRNA | 17942748 |
D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of PTPN1 mRNA | 25613284 |
C020809 | tetrathiomolybdate | tetrathiomolybdate inhibits the reaction [EGF protein results in increased oxidation of PTPN1 protein] | 18480265 |
D019284 | Thapsigargin | PTPN1 gene mutant form promotes the reaction [Thapsigargin results in increased activity of and results in increased phosphorylation of EIF2AK3 protein] | 22509299 |
D019284 | Thapsigargin | PTPN1 gene mutant form promotes the reaction [Thapsigargin results in increased activity of and results in increased phosphorylation of EIF2S1 protein] | 22509299 |
D019284 | Thapsigargin | PTPN1 gene mutant form promotes the reaction [Thapsigargin results in increased expression of DDIT3 mRNA] | 22509299 |
D019284 | Thapsigargin | PTPN1 gene mutant form promotes the reaction [Thapsigargin results in increased expression of DDIT3 protein] | 22509299 |
D019284 | Thapsigargin | PTPN1 gene mutant form promotes the reaction [Thapsigargin results in increased expression of HSPA5 mRNA] | 22509299 |
D019284 | Thapsigargin | PTPN1 gene mutant form promotes the reaction [Thapsigargin results in increased expression of HSPA5 protein] | 22509299 |
D019284 | Thapsigargin | PTPN1 gene mutant form promotes the reaction [Thapsigargin results in increased expression of XBP1 mRNA] | 22509299 |
D019284 | Thapsigargin | PTPN1 gene mutant form results in increased susceptibility to Thapsigargin | 22509299 |
D053778 | Thiazolidines | Thiazolidines analog inhibits the reaction [PTPN1 protein results in increased hydrolysis of nitrophenylphosphate] | 24287560 |
D053778 | Thiazolidines | Thiazolidines analog results in decreased activity of PTPN1 protein | 24287560 |
D014415 | Tunicamycin | PTPN1 gene mutant form promotes the reaction [Tunicamycin results in increased activity of and results in increased phosphorylation of EIF2AK3 protein] | 22509299 |
D014415 | Tunicamycin | PTPN1 gene mutant form promotes the reaction [Tunicamycin results in increased activity of and results in increased phosphorylation of EIF2S1 protein] | 22509299 |
D014415 | Tunicamycin | PTPN1 gene mutant form promotes the reaction [Tunicamycin results in increased expression of DDIT3 protein] | 22509299 |
D014415 | Tunicamycin | PTPN1 gene mutant form promotes the reaction [Tunicamycin results in increased expression of HSPA5 protein] | 22509299 |
D014415 | Tunicamycin | PTPN1 gene mutant form results in increased susceptibility to Tunicamycin | 22509299 |
C514931 | UA 0713 | UA 0713 results in decreased activity of PTPN1 protein | 26214522 |
C578831 | umbelliferone 6-carboxylic acid | umbelliferone 6-carboxylic acid results in decreased activity of PTPN1 protein | 27085377 |
C005466 | ursolic acid | ursolic acid results in decreased activity of PTPN1 protein | 27085377 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of PTPN1 mRNA | 23179753 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of PTPN1 mRNA | 20546886 |
D014638 | Vanadates | Vanadates inhibits the reaction [Acrolein results in decreased activity of PTPN1 protein] | 17655273 |
D014638 | Vanadates | Vanadates results in decreased activity of PTPN1 protein | 15924436 |
D014638 | Vanadates | Vanadates results in decreased activity of PTPN1 protein | 18534569|2237416 |
D014638 | Vanadates | Vanadates results in increased expression of PTPN1 protein | 17874149 |
C034028 | vanadyl sulfate | vanadyl sulfate results in decreased activity of PTPN1 protein | 10460753 |
C025643 | vinclozolin | vinclozolin results in decreased expression of PTPN1 mRNA | 23034163 |
C111237 | vorinostat | vorinostat results in increased expression of PTPN1 mRNA | 26238599 |
D015032 | Zinc | Zinc results in decreased activity of PTPN1 protein | 14644152 |
D015032 | Zinc | [Zinc co-treated with pyrithione] results in decreased activity of PTPN1 protein | 22374166 |
D019287 | Zinc Sulfate | Zinc Sulfate results in increased expression of PTPN1 mRNA | 27504894 |
D019287 | Zinc Sulfate | Zinc Sulfate results in decreased activity of PTPN1 protein | 10460753 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0003723 | RNA binding | - | HDA | 22658674 |
GO:0004725 | protein tyrosine phosphatase activity | - | IDA | 18074158 21707536 22169477 |
GO:0004725 | protein tyrosine phosphatase activity | - | TAS | - |
GO:0005158 | insulin receptor binding | - | IEA | - |
GO:0005515 | protein binding | - | IPI | 8702689 8940134 8999839 9050838 9355745 9407132 9418872 9566916 9600099 10660596 10889023 11007774 11106648 11163213 11506178 11579209 11694501 11970898 12023880 12176037 12237455 12614164 12634852 12857726 12907755 14527337 14722096 15588987 15821101 15866871 15894168 15976035 16115959 16271887 16388599 16537444 16582879 16644720 16926280 17092689 17128263 17159996 17197020 17416557 17481567 17974954 18387954 18515860 18579758 19029027 19167335 19712109 20627780 21806020 21972092 22789536 24658140 24976139 25796184 |
GO:0008270 | zinc ion binding | - | IDA | 18074158 |
GO:0019899 | enzyme binding | - | IPI | 22169477 |
GO:0019901 | protein kinase binding | - | IPI | 22169477 |
GO:0030971 | receptor tyrosine kinase binding | - | IPI | 18819921 |
GO:0045296 | cadherin binding | - | HDA | 25468996 |
GO:0046875 | ephrin receptor binding | - | IPI | 21135139 |
GO:0051721 | protein phosphatase 2A binding | - | IEA | - |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0006470 | protein dephosphorylation | - | IMP | 22045810 |
GO:0007257 | activation of JUN kinase activity | - | IEA | - |
GO:0008286 | insulin receptor signaling pathway | - | IEA | - |
GO:0009966 | regulation of signal transduction | - | IMP | 21135139 |
GO:0009968 | negative regulation of signal transduction | - | TAS | - |
GO:0030100 | regulation of endocytosis | - | IDA | 21135139 |
GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway | - | ISS | - |
GO:0030968 | endoplasmic reticulum unfolded protein response | - | IDA | 22169477 |
GO:0031532 | actin cytoskeleton reorganization | - | IMP | 21135139 |
GO:0033157 | regulation of intracellular protein transport | - | IMP | 22045810 |
GO:0034620 | cellular response to unfolded protein | - | TAS | 22013210 |
GO:0035335 | peptidyl-tyrosine dephosphorylation | - | IDA | 21135139 |
GO:0035335 | peptidyl-tyrosine dephosphorylation | - | IMP | 14966296 |
GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway | - | IMP | 14966296 |
GO:0036498 | IRE1-mediated unfolded protein response | - | IEA | - |
GO:0043407 | negative regulation of MAP kinase activity | - | IMP | 22045810 |
GO:0046627 | negative regulation of insulin receptor signaling pathway | - | NAS | 11742412 |
GO:0060338 | regulation of type I interferon-mediated signaling pathway | - | TAS | - |
GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway | - | TAS | - |
GO:0061098 | positive regulation of protein tyrosine kinase activity | - | IDA | 21216966 |
GO:0070373 | negative regulation of ERK1 and ERK2 cascade | - | ISS | - |
GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway | - | IMP | 18819921 |
GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway | - | IEA | - |
GO:1903896 | positive regulation of IRE1-mediated unfolded protein response | - | TAS | 22013210 |
GO:1903898 | negative regulation of PERK-mediated unfolded protein response | - | IDA | 21216966 |
GO:1990264 | peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity | - | ISS | - |
GO:2000646 | positive regulation of receptor catabolic process | - | IMP | 22045810 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005769 | early endosome | - | IDA | 21135139 |
GO:0005783 | endoplasmic reticulum | - | IDA | - |
GO:0005829 | cytosol | - | TAS | - |
GO:0005886 | plasma membrane | colocalizes_with | IDA | 21135139 |
GO:0097443 | sorting endosome | - | ISS | - |
GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane | - | IDA | 1739967 |
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-109582 | Hemostasis | TAS |
R-HSA-1280215 | Cytokine Signaling in Immune system | TAS |
R-HSA-1280215 | Cytokine Signaling in Immune system | IEA |
R-HSA-162582 | Signal Transduction | TAS |
R-HSA-168256 | Immune System | TAS |
R-HSA-168256 | Immune System | IEA |
R-HSA-354192 | Integrin alphaIIb beta3 signaling | TAS |
R-HSA-6806834 | Signaling by MET | TAS |
R-HSA-6807004 | Negative regulation of MET activity | TAS |
R-HSA-76002 | Platelet activation, signaling and aggregation | TAS |
R-HSA-76009 | Platelet Aggregation (Plug Formation) | TAS |
R-HSA-877300 | Interferon gamma signaling | IEA |
R-HSA-877312 | Regulation of IFNG signaling | IEA |
R-HSA-8848021 | Signaling by PTK6 | TAS |
R-HSA-8849472 | PTK6 Down-Regulation | TAS |
R-HSA-9006921 | Integrin signaling | TAS |
R-HSA-9006927 | Signaling by Non-Receptor Tyrosine Kinases | TAS |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | TAS |
R-HSA-909733 | Interferon alpha/beta signaling | TAS |
R-HSA-912694 | Regulation of IFNA signaling | TAS |
R-HSA-913531 | Interferon Signaling | TAS |
R-HSA-913531 | Interferon Signaling | IEA |
R-HSA-982772 | Growth hormone receptor signaling | IEA |
R-HSA-982772 | Growth hormone receptor signaling | TAS |
PMID | Title (Year) | Author | Journal |
---|---|---|---|
28287835 | Single Nucleotide Polymorphisms in the PTPN1 Gene Are Associated with Susceptibility to Esophageal Squamous Cell Carcinoma: A Case-Control Study in Inner Mongolia, China. (2017 May) | Ji HB | Genet Test Mol Biomarkers |